第19回 治験審査委員会・会議記録の概要
Contents
1. 11 JNS001 26 JNS001 11 JNS001 230003 1 JNS2. 220039 II b 2012 7 220040 CDP870 E 2012 7 27 220042 1 HEFT 290 2012 5 9 2012 7 2012 7 230001 2012 8 1 AD HD 2012 7 230003 AD HD 2012 7 1 230004 AD HD 2012 7 2 AD HD 230004 2
3. 2012 7 24 232002 TAP 144 SR 3M IL L 2012 7 31 213001 Ph CML CP 2012 7 25
4. I 1 2012 7 4 230043 2 L cabazitaxel CD I 2012 7 19 230049 1 1b C BMS 790052 BMS 650032 3 7 13 2012 7 230049 2 17 3 2012 7 230052 1
5. ei 2 3 Ee rr 11 13 NN wii 230043 230045 230047 230048 230049 230052 230053 230054 230054 230054 230056 240001 240004 240006 240007 240009 240010 240012 240016 240017 240018 240018 240019 240019 232001 232001 232002 232002 232003 194047 204055 214005 E7080 TAK 875 TFIXF c Cabazitaxel XRP6258 BMS 790052 BMB 650032 TKI258 KRP 209 IDE 102 DE 102 IDE 102 IFPF1100W 256U87 FK949E rFLXFc IFPF1100W TAP 144 SR 6W AJM300 ILFA102 OPC 14597 OPC 14597 ASPO15K ASPO15K ASPO15K
6. MK 7009 E 2012 7 31 230022 1 2012 7 20 230023 secukinumab
7. 2 8 232001 I 2012 6 4 29 2012 7 13 232002 TAP 144 SR 3M LL 2012 6 12 25 26 3 1
8. 2012 7 27 230035 MP 424 C Genotype2 2b 2012 7 24 230036 MP 424 C Genotype2 2b 2012 7 24 230037
9. 240010 AJM300 2 LIL 2012 8 14 we 94 190046 GW786034 GW786034 I 1 2012 7 31 200001 EO302 IL
10. b c 0 CDP870 MTX HH E 275 08 001 L CDP870 MTX 2012 8 8
11. TAP 144 SR 6M EE lt EE EE EE 2012 7 240009 3 118 TAP 144 SR 6M EN UL lt 5 5 EE EE 2012 8 1 240011 AK160 2012 7 1 30 8 13 240015
12. 3 13 220036 2 CNV VEGEF Trap Eye 2012 7 25 220037 1 TMC435 C 2012 7 11 2012 7 220038 2012 7 27 220037 2 TMC435 C 26 FE992026
13. 2012 7 26 230010 1 2012 7 4 GSK1605786A 1 230010 2 Hb H 18 220042 2 HFT 290 26 220042 3 FT 290 H 30 ON0 7643 II
14. MM 2012 7 27 6 240016 OPC 14597 2012 7 24 240017 OPC 14597 2012 7 24 232001 EGFR
15. IV 8 210026 CP 690 550 220026 A N8 230025 C MK 7009 230042 Attachment I PRO
16. 2012 7 10 220012 2012 7 10 220013 1 gt SB I087 2012 7 5 220013 2 EE 7 5B 087 1 LIL 2012 7 27 220016 AG 013736 Ei
17. 230030 2 KW 3357 DIC KW 3357 2012 7 27 E3810 230033 Pi E3810 I 2012 7 30 230034 CDP870 CDP870
18. NN li 2 EYE001 2012 8 2 DME 0 3mg sham 24 0 3mg 30 220009 JNS001 2012 7 13 JNS001 AD HD 230003 KPS 0373 2012 8 1 KPS 0373 230016 40mg
19. 2012 7 4 230012 2 GSK1605786A 2012 7 27 230013 1 DME VBGF Trap Eye 2012 7 10 230013 2 DME VBGF Trap Eye
20. 4 26 2012 7 240005 3 26 1 2012 7 240005 4 26 1 16 f E 1 16
21. 220036 1 CNV VEGF Trap Eye 2012 7 10
22. 2012 7 17 230025 C MK 7009 my 7 2b MSD 2012 26 0000 AMG 162 1 2012 7 12 230027 2 AMG 162 TI II 2012
23. Se f 2012 7 240009 1 26 1 1 1 16 1 5 TAP 144 SR 6M Ek lt EE EEE 2012 7 240009 2 H 4
24. 230017 C MK 7009 2b MSD 7 np 2b E MSD GVHD JR 031 IL HL
25. E kg BI6727 I a 1 f b EE c ey d 2 1 13 a 5 SOM230LAR
26. GVHD 2012 7 25 S 1 GS I II 13 13
27. 230032 2012 7 30 a 6 13 EE 2
28. 230011 1 2012 7 4 230011 2 3 Ed 2012 7 27 GSK1605786A GSK1605786A O 2012 7 25 230017
29. HI 2012 7 17 200002 E0302 2012 7 17 200027 CD20 indolent B IDEC C2B8 TL 2012 7 31 200029 CDP870 MTX CDP870 MTX 275 08 001 CDP870 MTX 200030 CDP870 MTX 1 CDP870
30. CCL 2012 7 19 230039 3 IgPro20 CGCL 2012 8 1 230042 GVHD JR 031 IL HL 2012 7 31 230043 DTC E7080
31. 0 230046 MC710 MI 230051 B Mi 9 13 CSL654 T rIX FP 240017
32. gt 7F7 TD 2012 7 5 210034 2 BI I 5 IT 2012 7 23 220003 1 L059 2012 7 10 220003 2 L059 2012 7 26 220011
33. 1 1 1 16 BMS 790052 BMS 650032 e E EE II
34. 13 EGR 11 J 2012 8 13 2012 8 1 TL CSL IMP OPC 14597 NR 24 7 4 24 8 3 1 Ap Ap Ap Paran Paran Ap Ap 190024 200027 210008 210033 210034 220001 220003 220007 220011 220013 22
35. SDAA 1 PAH NS 304 PAH LL IPF FE IPF LC 5 13 NS 304 NE GE CE BIBF 1120 150mg 1 2 52 BIBF 1120 150mg 1 2 52 230012 1 GSK1605786A
36. 210013 i E 2012 7 17 210026 1 2012 7 3 10 CP 690 550 2 1 3 2 210026 2 CP 690 550 2012 7 24 210034 1
37. 19 2012 8 20 8 Mi I 18 2012 IL 1 2012 8 rt 240021 16 00 17 40 CD 2 dd 240022 ER 200029 CDP870 MTX b 1
38. 3 2012 7 30 230047 B Fc rFIXFc 7 7 2012 7 31 230048 1 cabazitaxe1
39. 0 8mL 2012 7 27 40mg 0 8mL D2E7 MO6 859 224027 3 3 1 BK 4SP 2012 7 27 BK 4SP 200006 4 2012 7 25 2012 7 25 2012 7 25
40. 2012 7 27 MTX f 275 08 003 O 2E7 IT MTX CDP870 2012 7 27 210008 2012 7 24
41. ASPO15K ZD1839 ZD1839 TAP 144 SR 3W TAP 144 SR 3M IFPF300 HIV 0 3mg 0 9mg A AH D D DO ei D ke D DO DO 12 13
42. 2012 7 20 230038 1 INC424 T 2012 7 13 230038 2 I I RE INC4224 0 T 2012 7 27 230039 1 IgPro20 CSGL 2012 7 4 230039 2 IgPro20
43. TKI258 2012 7 230052 2 EX 2012 7 240004 2012 7 240005 1 19 1 13 0 1 27 1 30 VEGE VEGF TKI258 1b C mTOR mTORE f 2012 7 240005 2
44. 2b PEON RN MS FE 7 26 2012 230018 1 C D TL 2012 7 230018 2 12 2012 7 230021 1 2012 7 230021 2 H 5 13
45. 7 25 230029 1 KW 3357 TDIC DIC KW 3357 2012 7 5 230029 2 KW 3357 DIC DIC KW 3357 2012 7 27 230030 1 KW 3357 DIC KW 3357 2012 7 5
46. 001 gt GSK1605786A E E 4 13 2012 7 27
47. 0024 220025 220035 220035 220036 220037 Ap Ap Ap Ap Ap Ap Paran 220038 230001 230001 230009 230010 230013 230014 230018 230019 230020 230021 230022 230026 230026 230026 230037 230037 230042 HH T 614 IDEC C2B8 D2E7 NJ 26866138 BAY43 9006 PNFD L059 MRA SC OPC 14597 SBI 087 BIBW2992 MORAb 003 BAY86 5321 TMC435 FE992026 ON0 7643 OO 7643 GSK1605786A BAY86 5321 ON0 1101 NS 304 SAR245408 NPB 01 BIBF1120 DE 102 DE 102 DE 102 JR 031 A AN A
48. 2 2012 7 17 RY 220019 SK 0503 II 2012 7 26 220024 1 BIBW2992 1 2012 7 12 220024 2 BIBWw2992 1 2012 7 30
Download Pdf Manuals
Related Search